Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene

Summary

Current screening methods for factor VIII gene (F8) mutations can reveal the causative alteration in the vast majority of haemophilia A patients. Yet, standard diagnostic methods fail in about 2 % of cases. This study aimed at analysing the entire intronic sequences of the F8 gene in 15 haemophilia A patients by next generation sequencing. All patients had a mild to moderate phenotype and no mutation in the coding sequence and splice sites of the F8 gene could be diagnosed so far. Next generation sequencing data revealed 23 deep intronic candidate variants in several F8 introns, including six recurrent variants and three variants that have been described before. One patient additionally showed a deletion of 9.2 kb in intron 1, mediated by Alu-type repeats. Several bioinformatic tools were used to score the variants in comparison to known pathogenic F8 mutations in order to predict their deleteriousness. Pedigree analyses showed a correct segregation pattern for three of the presumptive mutations. In each of the 15 patients analysed, at least one deep intronic variant in the F8 gene was identified and predicted to alter F8 mRNA splicing. Reduced F8 mRNA levels and/or stability would be well compatible with the patients’ mild to moderate haemophilia A phenotypes. The next generation sequencing approach used proved an efficient method to screen the complete F8 gene and could be applied as a one-stop sequencing method for molecular diagnostics of haemophilia A.

Note: The work was carried out at the Department of Human Genetics, University of Würzburg, Biocenter, Am Hubland, 97074 Würzburg, Germany. New

Keywords

Alternative splice sites - deep intronic variant - factor VIII - haemophilia A - next generation sequencing

• References

• 1 Graw J, Brackmann HH, Oldenburg J. et al. Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet 2005; 6: 488-501.
• 2 Oldenburg J, El-Maarri O. New insight into the molecular basis of hemophilia A. Int J Hematol 2006; 83: 96-102.
• 3 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003; 361: 1801-1809.
• 4 Bogdanova N, Markoff A, Eisert R. et al. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat 2007; 28: 54-60.
• 5 Gitschier J, Wood WI, Goralka TM. et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-330.
• 6 Oldenburg J, Ananyeva NM, Saenko EL. Molecular basis of haemophilia A. Haemophilia 2004; 10 (Suppl. 04) 133-139.
• 7 Bagnall RD, Waseem N, Green PM. et al. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002; 99: 168-174.
• 8 Naylor JA, Buck D, Green P. et al. Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet 1995; 4: 1217-1224.
• 9 Castaman G, Giacomelli SH, Mancuso ME. et al. Deep intronic variations may cause mild hemophilia A. J Thromb Haemost 2011; 9: 1541-1548.
• 10 Pezeshkpoor B, Zimmer N, Marquardt N. et al. Deep intronic ’mutations’ cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA. J Thromb Haemost 2013; 11: 1679-1687.
• 11 Inaba H, Koyama T, Shinozawa K. et al. Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A. Haemophilia 2013; 19: 100-105.
• 12 Bagnall RD, Waseem NH, Green PM. et al. Creation of a novel donor splice site in intron 1 of the factor VIII gene leads to activation of a 191 bp cryptic exon in two haemophilia A patients. Br J Haematol 1999; 107: 766-771.
• 13 Youssoufian H, Kazazian Jr. HH, Patel A. et al. Mild hemophilia A associated with a cryptic donor splice site mutation in intron 4 of the factor VIII gene. Genomics 1988; 2: 32-36.
• 14 Smit AFA, Hubley R, Green P. RepeatMasker Web Server. Available at: http://www.repeatmasker.org Accessed October 22, 2013.
• 15 Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-394.
• 16 Reese MG, Eeckman FH, Kulp D. et al. Improved splice site detection in Genie. J Comput Biol 1997; 4: 311-323.
• 17 Pertea M, Lin X, Salzberg SL. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res 2001; 29: 1185-1190.
• 18 Desmet FO, Hamroun D, Lalande M. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009; 37: e67.
• 19 Cartegni L, Wang J, Zhu Z. et al. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571.
• 20 Fairbrother WG, Yeh RF, Sharp PA. et al. Predictive identification of exonic splicing enhancers in human genes. Science 2002; 297: 1007-1013.
• 21 Kircher M, Witten DM, Jain P. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310-315.
• 22 University of Washington and Hudson-Alpha Institute for Biotechnology.. Combined Annotation Dependent Depletion (CADD). Available at: http://cadd.gs.washington.edu/score Accessed April 29, 2014.
• 23 Machado FB, Medina-Acosta E. High-resolution combined linkage physical map of short tandem repeat loci on human chromosome band Xq28 for indirect haemophilia A carrier detection. Haemophilia 2009; 15: 297-308.
• 24 Castaman G, Giacomelli SH, Mancuso ME. et al. F8 mRNA studies in haemophilia A patients with different splice site mutations. Haemophilia 2010; 16: 786-790.
• 25 Sherry ST, Ward MH, Kholodov M. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-311.
• 26 Genomes Project C, Abecasis GR, Auton A. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
• 27 Altschul SF, Gish W, Miller W. et al. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.
• 28 Yang YH, Song KS, Kim IK. et al. Rapid polymerase chain reaction analysis of St14 (DXS52) VNTR: carrier detection of hemophilia A. J Obstet Gynaecol Res 1997; 23: 399-406.
• 29 Vidal F, Farssac E, Tusell J. et al. First molecular characterization of an unequal homologous alu-mediated recombination event responsible for hemophilia. Thromb Haemost 2002; 88: 12-16.
• 30 Rossetti LC, Goodeve A, Larripa IB. et al. Homeologous recombination between AluSx-sequences as a cause of hemophilia. Hum Mutat 2004; 24: 440.
• 31 Nakaya SM, Hsu TC, Geraghty SJ. et al. Severe hemophilia A due to a 1.3 kb factor VIII gene deletion including exon 24: homologous recombination between 41 bp within an Alu repeat sequence in introns 23 and 24. J Thromb Haemost 2004; 2: 1941-1945.
• 32 Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab 1999; 67: 183-193.
• 33 Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336.
• 34 Santacroce R, Santoro R, Sessa F. et al. Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy. Blood Coagul Fibrinolysis 2008; 19: 197-202.
• 35 Hughes TA. Regulation of gene expression by alternative untranslated regions. Trends Genet 2006; 22: 119-122.
• 36 McGlincy NJ, Smith CW. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?. Trends Biochem Sci 2008; 33: 385-393.
• 37 Zimmermann MA, Gehrig A, Oldenburg J. et al. Analysis of F8 mRNA in haemophilia A patients with silent mutations or presumptive splice site mutations. Haemophilia 2013; 19: 310-317.
• 38 Chen JM, Ferec C, Cooper DN. Closely spaced multiple mutations as potential signatures of transient hypermutability in human genes. Hum Mutat 2009; 30: 1435-1448.
• 39 Cooper DN, Krawczak M. Human Gene Mutation Database. Hum Genet 1996; 98: 629.